Holen Sie sich die Stockscreener-App
5.32
4.14%
-0.23
Vorhandelsmarkt:
4.78
-0.54
-10.15%
Gri Bio Inc Aktie (GRI) Neueste Nachrichten
GRI Bio secures U.S. composition of matter patent - TipRanks
New GRI Bio patent covers compounds for inflammatory and autoimmune diseases - Stock Titan
Trade Recap: Is DB Gold Double Short ETN stock a buy or sellTrade Signal Summary & Real-Time Market Sentiment Reports - baoquankhu1.vn
Analysis Recap: Can Viavi Solutions Inc withstand a market correction2025 Breakouts & Breakdowns & Smart Investment Allocation Tips - baoquankhu1.vn
Trade Report: Is GRI Bio Inc in a long term uptrendNew Guidance & Consistent Growth Stock Picks - baoquankhu1.vn
GRI Bio To Carry Out 1-for-28 Reverse Stock Split On January 26th, 2026 - 富途牛牛
GRI Bio announces 1-for-28 reverse stock split to regain Nasdaq compliance - Investing.com Nigeria
GRI Bio Announces Reverse Stock Split To Regain Minimum Bid Price Nasdaq Compliance - Nasdaq
Gri Bio Announces Reverse Stock Split - TradingView
GRI Bio Announces 1-for-28 Reverse Stock Split - TipRanks
GRI Bio stock falls after announcing 1-for-28 reverse split By Investing.com - Investing.com South Africa
GRI Bio stock falls after announcing 1-for-28 reverse split - Investing.com Nigeria
GRI Bio (NASDAQ: GRI) plans 1-for-28 reverse stock split in January - Stock Titan
GRI Bio slashes share count with 1-for-28 split to meet Nasdaq price rule - Stock Titan
GRI Bio conditionally regains Nasdaq compliance with equity listing rule By Investing.com - Investing.com Nigeria
GRI Bio conditionally regains Nasdaq compliance with equity listing rule - Investing.com
GRI Bio Regains Conditional Compliance With Nasdaq Listing Requirements - TipRanks
Short Covering: Is GCTSWS stock a good pick for beginnersJuly 2025 Chart Watch & Expert Approved Trade Ideas - baoquankhu1.vn
GRI Bio shareholders approve reverse stock split and report Nasdaq compliance - Investing.com Nigeria
GRI Bio Shareholders Authorize Reverse Stock Split Plan - TipRanks
GRI Bio (NASDAQ: GRI) wins reverse split approval and addresses Nasdaq equity risk - Stock Titan
GRI: Reverse stock split and adjournment proposals approved; results to be filed on Form 8-K - TradingView
Gains Recap: Why GRI Bio Inc stock remains on watchlistsJuly 2025 Big Picture & Low Risk Investment Opportunities - Bộ Nội Vụ
Options Flow: What insider trading reveals about GRI Bio Inc. stockEarnings Trend Report & Smart Money Movement Alerts - Bộ Nội Vụ
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Market Recap: What makes GRI Bio Inc stock attractive todayJuly 2025 Snapshot & Fast Moving Trade Plans - baoquankhu1.vn
GRI Bio approves reverse stock split, stockholders vote in favor - MSN
GRI Bio, Inc.Common Stock (NQ: GRI - FinancialContent
GRI Bio announces pricing of $8M public offering - MSN
GRI Bio increases at-the-market offering capacity to $7.38 million - Investing.com Nigeria
GRI Bio reports positive Phase 2a data for IPF treatment By Investing.com - Investing.com Nigeria
GRI Bio Expands At-The-Market Equity Offering Capacity - TipRanks
GRI Bio, Inc. Increases Share Issuance Limit - TradingView — Track All Markets
Can GRI Bio Inc. stock sustain institutional interestCushioning Options Review & trail grip notes for mixed terrain - ulpravda.ru
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Is GRI Bio Inc. stock affected by interest rate hikesWall Street Watch & Safe Entry Trade Signal Reports - Улправда
Can GRI Bio Inc. stock weather global recession2025 Price Targets & Community Consensus Trade Signals - ulpravda.ru
GRI Bio stock rises on positive Phase 2a immune data for IPF treatment - Investing.com Australia
GRI Bio reports positive Phase 2a data for IPF treatment - Investing.com
GRI Bio Announces Additional Positive Data from Phase 2a Study in Idiopathic Pulmonary Fibrosis, Strengthening Clinical Proof-of-Concept for GRI-0621 - The Manila Times
GRI Bio, Inc. Announces Positive Phase 2a Trial Data for GRI-0621 - TradingView — Track All Markets
GRI Bio Announces Additional Positive Data from Phase 2a - GlobeNewswire
GRI Bio reports six-week interim safety outcomes from trial of GRI-0621 for IPF - MSN
What Wall Street predicts for GRI Bio Inc. stock priceBullish Engulfing Patterns & Small Entry Portfolio - Улправда
What technical signals suggest for GRI Bio Inc. stock2026 world cup usa national team third place match goalkeepers high defensive line group prediction insights - ulpravda.ru
What drives GRI Bio Inc stock priceEarnings Forecast Updates & High Yield Trading Growth - earlytimes.in
Decliners Report: Is GRI Bio Inc stock attractive for hedge funds2025 Bull vs Bear & Free Community Consensus Stock Picks - moha.gov.vn
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
GRI Bio Inc. (GRI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
2.09%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):